Taipei Heart Institute (THI), Taipei Medical University

Medicine & Life Sciences

1. Atrial Fibrillation 100%
2. Pulmonary Veins 84%
3. Cardiac Myocytes 57%
4. Taiwan 42%
5. Heart Failure 41%
6. Catheter Ablation 38%
7. Calcium 37%
8. Endothelial Cells 30%
9. Cardiac Arrhythmias 30%
10. Heart Atria 30%
11. Endothelin-1 29%
12. Coronary Vessels 27%
13. Cohort Studies 25%
14. Blood Pressure 25%
15. Endothelial Progenitor Cells 24%
16. trilinolein 24%
17. Population 23%
18. Myocardial Infarction 23%
19. Reactive Oxygen Species 23%
20. Therapeutics 23%
21. Hypertension 22%
22. Antioxidants 21%
23. Angiotensin II 20%
24. Heart 20%
25. Cardiovascular Diseases 19%
26. Fibroblasts 18%
27. Action Potentials 18%
28. Rabbits 18%
29. Oxidative Stress 17%
30. Inflammation 17%
31. Hydroxymethylglutaryl-CoA Reductase Inhibitors 17%
32. Nicorandil 17%
33. Smooth Muscle Myocytes 17%
34. Proteins 16%
35. Homeostasis 16%
36. Coronary Artery Disease 16%
37. Chronic Renal Insufficiency 16%
38. Vaccination 16%
39. Human Influenza 16%
40. Atrial Flutter 15%
41. Mortality 15%
42. Electrocardiography 15%
43. Stroke 15%
44. Phosphorylation 14%
45. Electrophysiology 14%
46. Apoptosis 14%
47. Kidney 14%
48. Confidence Intervals 14%
49. Blood Vessels 14%
50. Hypertrophy 14%
51. Histone Deacetylases 13%
52. Muscle Cells 13%
53. Peroxisome Proliferator-Activated Receptors 13%
54. Pravastatin 13%
55. Atherosclerosis 13%
56. Sinoatrial Node 13%
57. Elderly 13%
58. Gene Expression 13%
59. Neoplasms 13%
60. Superoxide Dismutase 13%
61. Down-Regulation 12%
62. stevioside 12%
63. Human Umbilical Vein Endothelial Cells 12%
64. Diabetes Mellitus 12%
65. Nitric Oxide 12%
66. Atrial Remodeling 12%
67. Inbred SHR Rats 11%
68. Type 2 Diabetes Mellitus 11%
69. Pharmaceutical Preparations 11%
70. KATP Channels 11%
71. Infarction 11%
72. Heme Oxygenase-1 11%
73. Incidence 11%
74. Ventricular Remodeling 11%
75. Lipids 11%
76. Extracellular Signal-Regulated MAP Kinases 11%
77. Hospitalization 11%
78. Ventricular Tachycardia 11%
79. Fibrosis 10%
80. In Vitro Techniques 10%
81. Tachycardia 10%
82. urotensin II 10%
83. Nitric Oxide Synthase Type III 10%
84. Glyburide 10%
85. Chronic Obstructive Pulmonary Disease 10%
86. Western Blotting 10%
87. Sitagliptin Phosphate 10%
88. Lithium 10%
89. p38 Mitogen-Activated Protein Kinases 10%
90. Glucose 10%
91. Antihypertensive Agents 9%
92. tanshinone 9%
93. Collagen 9%
94. Computed Tomography Angiography 9%
95. Cardiology 9%
96. LCZ 696 9%
97. Messenger RNA 9%
98. Exercise 9%
99. Wounds and Injuries 9%
100. oxidized low density lipoprotein 9%